Insider Cluster (3 insiders) ·Filed Mar 30, 2026

INSM

INSMED Inc
BEARISH
Impact 7/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $4.1M total
Actionable Insight ▼ Bearish

Traders should watch for potential downward pressure on the stock, especially if additional insiders sell. The concentration of sales among C-suite executives, including the CEO, suggests possible lack of confidence despite non-cash option exercises being routine.

DirectionBearish
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
INSM ▼ -31.86% at T+60d
SHORT call ✓ call won +31.86% · α vs SPY +48.35% · entry $153.32 → $104.47
Entry anchored
Mar 27, 03:59 PM ET
via exchange tick
T+1d
+6.65%
call -6.65% · α -3.76%
$163.52
settled 6mo ago
T+5d
+6.33%
call -6.33% · α -2.03%
$163.03
settled 6mo ago
T+20d
-11.99%
call +11.99% · α +24.58%
$134.94
settled 5mo ago
T+60d
-31.86%
call +31.86% · α +48.35%
$104.47
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Two C-suite executives at INSMED Inc sold shares in early April, generating $4.06M in open-market proceeds. CEO Lewis William also exercised options and sold a small portion of shares for $127K, part of a broader insider selling cluster totaling $4.4M in the last 30 days.

Key Financial Metrics

Direction
selling
Total Value
$4.1M
Insiders
3

Key Facts

  • Chief Operating Officer Adsett Roger sold 6,700 shares at $163.18 for $1.10M on 2026-04-01
  • Chief Legal Officer Smith Michael Alexander sold 19,600 shares at $150.98 for $2.96M on 2026-03-30
  • CEO Lewis William exercised options and sold 787 shares for $127,281 on 2026-04-06
  • Total open-market insider sales in the 7-day cluster: $4.06M; $4.4M over the past 30 days
  • Total insider selling represents 0.012% of the $35.2B market cap, but is concentrated among top executives

Financial Impact

$4.06M in net insider selling over 7 days, with $4.4M in total sales over the past 30 days

insider ownershipmarket sentimentdilution perception

Risk Factors

  • Perceived lack of confidence from top executives could erode investor sentiment
  • Risk of follow-on selling by other insiders or institutions

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-INSM-1775680923566
18 reports for INSM
Performance horizon
83% Hit rate 5 of 6 directional calls best @ T+60▲ +31.86%Mar 30, 2026
Filters
Rows
Reports for INSM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 4/10
$130.66 $119.92▼ −8.22%▼ −6.70%$111.12 (−14.95%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$126.33 $129.41▲ +2.44%▲ +4.19%$111.12 (−12.04%)
Aug 6, 2026
8w ago
8-K
BULLISH ★ 8/10
$132.55 $126.68▼ −4.43%▼ −5.03%$111.12 (−16.17%)
Jul 24, 2026
10w ago
Institutional Cluster
NEUTRAL ★ 4/10
$106.92 $125.77▲ +17.63%▲ +14.00%$111.12 (+3.93%)
Jul 21, 2026
10w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$108.62 $128.46▲ +18.27%▲ +15.70%$111.12 (+2.30%)
Jul 16, 2026
11w ago
8-K
BULLISH ★ 6/10
$107.46 $126.33▲ +17.56%▲ +13.94%$111.12 (+3.41%)
Jun 26, 2026
14w ago
Insider Cluster
NEUTRAL ★ 2/10
$104.74 $106.92▲ +2.08%▲ +2.36%$111.12 (+6.09%)
Jun 5, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$111.12 (+18.00%)
Jun 5, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$94.17 $111.54▲ +18.45%▲ +16.81%$111.12 (+18.00%)
May 15, 2026
19w ago
S-3ASR
NEUTRAL ★ 3/10
$107.15 $95.52▼ −10.85%▼ −12.44%$111.12 (+3.71%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 41m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Apr 8, 2026